Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Choukroun

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Kidney International|September 28, 2007
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendationsD C Cattran, E Alexopoulos, P Heering, et al.
Journal of Thrombosis and Haemostasis : JTH|August 5, 2014
Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French studyA Widemann, C Pasero, L Arnaud, et al.
Journal of Clinical Pathology|October 30, 2015
Vascular expression of annexin A2 in lupus nephritisV Salle, C Cordonnier, J Schmidt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2010
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF StudyF Martinez, N Kamar, N Pallet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.
Clinical Pharmacology and Therapeutics|April 16, 2010
Optimization of initial tacrolimus dose using pharmacogenetic testingE Thervet, M A Loriot, S Barbier, et al.
Journal of Transplantation|May 16, 2014
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity studyA Thierry, G Mourad, M Büchler, et al.
Trials|June 23, 2019
PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled studyE Gaiffe, T Crepin, J Bamoulid, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2015
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrationsN Pallet, A-S Jannot, M El Bahri, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 7, 2016
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic ScreeningC Damon, M Luck, L Toullec, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Kidney International|September 28, 2007
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendationsD C Cattran, E Alexopoulos, P Heering, et al.
Journal of Thrombosis and Haemostasis : JTH|August 5, 2014
Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French studyA Widemann, C Pasero, L Arnaud, et al.
Journal of Clinical Pathology|October 30, 2015
Vascular expression of annexin A2 in lupus nephritisV Salle, C Cordonnier, J Schmidt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2010
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF StudyF Martinez, N Kamar, N Pallet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.
Clinical Pharmacology and Therapeutics|April 16, 2010
Optimization of initial tacrolimus dose using pharmacogenetic testingE Thervet, M A Loriot, S Barbier, et al.
Journal of Transplantation|May 16, 2014
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity studyA Thierry, G Mourad, M Büchler, et al.
Trials|June 23, 2019
PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled studyE Gaiffe, T Crepin, J Bamoulid, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2015
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrationsN Pallet, A-S Jannot, M El Bahri, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 7, 2016
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic ScreeningC Damon, M Luck, L Toullec, et al.
Pageof 10